N V Tho1, H T H Loan2, N T P Thao3, N T T Dung4, L T T Lan5. 1. Department of Tuberculosis and Lung Diseases, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam ; Respiratory Care Centre, University Medical Centre at Ho Chi Minh City, Ho Chi Minh City, Viet Nam. 2. Health Care Centre of Phu Nhuan District, Ho Chi Minh City, Viet Nam. 3. Health Care Centre of Hoc Mon District, Ho Chi Minh City, Viet Nam. 4. Regional General Hospital of Thu Duc District, Ho Chi Minh City, Viet Nam. 5. Respiratory Care Centre, University Medical Centre at Ho Chi Minh City, Ho Chi Minh City, Viet Nam ; Department of Physiology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
Abstract
SETTING: The Global Initiative for Asthma (GINA) guidelines have not been implemented effectively in primary care settings in Viet Nam. OBJECTIVES: To estimate the proportion of patients with controlled asthma and the direct health care costs of managing asthma according to GINA guidelines at four out-patient clinics in Ho Chi Minh City (HCMC), Viet Nam. METHODS: One hundred and six patients with asthma were treated and followed up according to GINA guidelines for 12 months. Clinical and pulmonary function responses and direct health care costs were evaluated every 3 months during the study. RESULTS: The proportion of patients with controlled asthma rose from 1.0% at the start of the study to 36.8% by the end of the study (P < 0.0001). The proportion of patients who had at least one hospitalisation per year decreased significantly, from 32.1% to 5.7% (P < 0.0001). The annual per patient median direct health care cost was US$169. Using asthma controllers continuously gave better asthma control than using them intermittently (OR 12.9, 95%CI 4.7-35.7). CONCLUSIONS: The implementation of GINA guidelines at out-patient clinics in HCMC, Viet Nam, improved asthma control with modest direct health care costs.
SETTING: The Global Initiative for Asthma (GINA) guidelines have not been implemented effectively in primary care settings in Viet Nam. OBJECTIVES: To estimate the proportion of patients with controlled asthma and the direct health care costs of managing asthma according to GINA guidelines at four out-patient clinics in Ho Chi Minh City (HCMC), Viet Nam. METHODS: One hundred and six patients with asthma were treated and followed up according to GINA guidelines for 12 months. Clinical and pulmonary function responses and direct health care costs were evaluated every 3 months during the study. RESULTS: The proportion of patients with controlled asthma rose from 1.0% at the start of the study to 36.8% by the end of the study (P < 0.0001). The proportion of patients who had at least one hospitalisation per year decreased significantly, from 32.1% to 5.7% (P < 0.0001). The annual per patient median direct health care cost was US$169. Using asthma controllers continuously gave better asthma control than using them intermittently (OR 12.9, 95%CI 4.7-35.7). CONCLUSIONS: The implementation of GINA guidelines at out-patient clinics in HCMC, Viet Nam, improved asthma control with modest direct health care costs.
Authors: M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger Journal: Eur Respir J Date: 2005-08 Impact factor: 16.671
Authors: Christopher K W Lai; Teresita S De Guia; You-Young Kim; Sow-Hsong Kuo; Amartya Mukhopadhyay; Joan B Soriano; Pham Long Trung; Nan Shan Zhong; Norzila Zainudin; B M Z Zainudin Journal: J Allergy Clin Immunol Date: 2003-02 Impact factor: 10.793
Authors: John Haughney; David Price; Alan Kaplan; Henry Chrystyn; Rob Horne; Nick May; Mandy Moffat; Jennifer Versnel; Eamonn R Shanahan; Elizabeth V Hillyer; Alf Tunsäter; Leif Bjermer Journal: Respir Med Date: 2008-09-23 Impact factor: 3.415
Authors: Eric D Bateman; Homer A Boushey; Jean Bousquet; William W Busse; Tim J H Clark; Romain A Pauwels; Søren E Pedersen Journal: Am J Respir Crit Care Med Date: 2004-07-15 Impact factor: 21.405
Authors: Stephen P Peters; Craig A Jones; Tmirah Haselkorn; David R Mink; David J Valacer; Scott T Weiss Journal: J Allergy Clin Immunol Date: 2007-05-03 Impact factor: 10.793
Authors: Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft Journal: J Allergy Clin Immunol Date: 2004-01 Impact factor: 10.793